Literature DB >> 30310452

Guest Editorial: Controversies in Fractional Flow Reserve.

Maria Chiara Scali1, Doralisa Morrone2, Mario Marzilli2.   

Abstract

Fractional flow reserve (FFR) has been identified as the optimal diagnostic tool to identify significant coronary lesion. However, current evidence does not support this role. The optimal diagnostic strategy should give highly sensitive and specific results with lowest cost and accomplishing this task has been made more difficult in the era following the COURAGE trial.

Entities:  

Keywords:  COURAGE trial; Fractional flow reserve; diagnostic tool

Year:  2016        PMID： 30310452      PMCID： PMC6159422          DOI： 10.15420/ecr.11.2:ED3

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN： 1758-3756


  14 in total

1.  Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.

Authors:  William F Fearon; Bernhard Bornschein; Pim A L Tonino; Raffaella M Gothe; Bernard De Bruyne; Nico H J Pijls; Uwe Siebert
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

2.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

Authors:  Gilles Montalescot; Udo Sechtem; Stephan Achenbach; Felicita Andreotti; Chris Arden; Andrzej Budaj; Raffaele Bugiardini; Filippo Crea; Thomas Cuisset; Carlo Di Mario; J Rafael Ferreira; Bernard J Gersh; Anselm K Gitt; Jean-Sebastien Hulot; Nikolaus Marx; Lionel H Opie; Matthias Pfisterer; Eva Prescott; Frank Ruschitzka; Manel Sabaté; Roxy Senior; David Paul Taggart; Ernst E van der Wall; Christiaan J M Vrints; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Juhani Knuuti; Marco Valgimigli; Héctor Bueno; Marc J Claeys; Norbert Donner-Banzhoff; Cetin Erol; Herbert Frank; Christian Funck-Brentano; Oliver Gaemperli; José R Gonzalez-Juanatey; Michalis Hamilos; David Hasdai; Steen Husted; Stefan K James; Kari Kervinen; Philippe Kolh; Steen Dalby Kristensen; Patrizio Lancellotti; Aldo Pietro Maggioni; Massimo F Piepoli; Axel R Pries; Francesco Romeo; Lars Rydén; Maarten L Simoons; Per Anton Sirnes; Ph Gabriel Steg; Adam Timmis; William Wijns; Stephan Windecker; Aylin Yildirir; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2013-08-30       Impact factor: 29.983

Review 3.  Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.

Authors:  K Lance Gould; Nils P Johnson; Timothy M Bateman; Rob S Beanlands; Frank M Bengel; Robert Bober; Paolo G Camici; Manuel D Cerqueira; Benjamin J W Chow; Marcelo F Di Carli; Sharmila Dorbala; Henry Gewirtz; Robert J Gropler; Philipp A Kaufmann; Paul Knaapen; Juhani Knuuti; Michael E Merhige; K Peter Rentrop; Terrence D Ruddy; Heinrich R Schelbert; Thomas H Schindler; Markus Schwaiger; Stefano Sdringola; John Vitarello; Kim A Williams; Donald Gordon; Vasken Dilsizian; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

Review 4.  Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the Society of Cardiovascular Angiography and Interventions.

Authors:  Amir Lotfi; Allen Jeremias; William F Fearon; Marc D Feldman; Roxana Mehran; John C Messenger; Cindy L Grines; Larry S Dean; Morton J Kern; Lloyd W Klein
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-13       Impact factor: 2.692

5.  Stress echo applications beyond coronary artery disease.

Authors:  Eugenio Picano; Patricia A Pellikka
Journal:  Eur Heart J       Date:  2013-10-14       Impact factor: 29.983

6.  Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity.

Authors:  Tim P van de Hoef; Martijn A van Lavieren; Peter Damman; Ronak Delewi; Martijn A Piek; Steven A J Chamuleau; Michiel Voskuil; José P S Henriques; Karel T Koch; Robbert J de Winter; Jos A E Spaan; Maria Siebes; Jan G P Tijssen; Martijn Meuwissen; Jan J Piek
Journal:  Circ Cardiovasc Interv       Date:  2014-04-29       Impact factor: 6.546

7.  Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis.

Authors:  Steven A J Chamuleau; Martijn Meuwissen; Karel T Koch; Berthe L F van Eck-Smit; Rene A Tio; Jan G P Tijssen; Jan J Piek
Journal:  Am J Cardiol       Date:  2002-02-15       Impact factor: 2.778

8.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.

Authors:  Pim A L Tonino; Bernard De Bruyne; Nico H J Pijls; Uwe Siebert; Fumiaki Ikeno; Marcel van' t Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; William F Fearon
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

9.  Coronary flow reserve during dipyridamole stress echocardiography predicts mortality.

Authors:  Lauro Cortigiani; Fausto Rigo; Sonia Gherardi; Francesco Bovenzi; Sabrina Molinaro; Eugenio Picano; Rosa Sicari
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

Review 10.  Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!

Authors:  Mario Marzilli; C Noel Bairey Merz; William E Boden; Robert O Bonow; Paola G Capozza; William M Chilian; Anthony N DeMaria; Giacinta Guarini; Alda Huqi; Doralisa Morrone; Manesh R Patel; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2012-09-11       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.